Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-20-007544
Filing Date
2020-03-27
Accepted
2020-03-26 17:47:41
Documents
62
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f10k2019_tffpharma.htm 10-K 765724
2 WARRANT DATED OCTOBER 29, 2019 ISSUED TO NATIONAL SECURITIES CORPORATION f10k2019ex4-7_tffpharma.htm EX-4.7 101014
3 WARRANT DATED NOVEMBER 20, 2019 ISSUED TO NATIONAL SECURITIES CORPORATION f10k2019ex4-8_tffpharma.htm EX-4.8 100230
4 LIST OF SUBSIDIARIES f10k2019ex21-1_tffpharma.htm EX-21.1 910
5 CERTIFICATION f10k2019ex31-1_tffpharma.htm EX-31.1 9880
6 CERTIFICATION f10k2019ex31-2_tffpharma.htm EX-31.2 9959
7 CERTIFICATION f10k2019ex32-1_tffpharma.htm EX-32.1 6066
14 GRAPHIC image_001.jpg GRAPHIC 106742
  Complete submission text file 0001213900-20-007544.txt   3428459

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE FILE tffp-20191231.xml EX-101.INS 414301
9 XBRL SCHEMA FILE tffp-20191231.xsd EX-101.SCH 42144
10 XBRL CALCULATION FILE tffp-20191231_cal.xml EX-101.CAL 32070
11 XBRL DEFINITION FILE tffp-20191231_def.xml EX-101.DEF 118426
12 XBRL LABEL FILE tffp-20191231_lab.xml EX-101.LAB 267268
13 XBRL PRESENTATION FILE tffp-20191231_pre.xml EX-101.PRE 205326
Mailing Address 2600 VIA FORTUNA, SUITE 360 AUSTIN TX 78746
Business Address 2600 VIA FORTUNA, SUITE 360 AUSTIN TX 78746 737-802-1973
TFF Pharmaceuticals, Inc. (Filer) CIK: 0001733413 (see all company filings)

EIN.: 824344737 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39102 | Film No.: 20747224
SIC: 2834 Pharmaceutical Preparations